Dr. Ohad Sheffy, MD

Dr. Sheffy practices at Westminster-Canterbury on Chesapeake Bay in Virginia Beach, Virginia.

Dr. Sheffy's NPI, 1295087005, was assigned on October 4, 2012. Dr. Sheffy holds Virginia license 0101255566.

Dr. Sheffy's primary practice is Westminster-Canterbury on Chesapeake Bay, at 3100 Shore Drive, Virginia Beach, VA 23451 in Virginia Beach City. The practice phone is (757) 496-1158.

Dr. Sheffy's primary practice is Westminster-Canterbury on Chesapeake Bay in Virginia Beach, Virginia. Dr. Sheffy is also affiliated with Sentara Virginia Beach General Hospital. The medical group on file is Calvert Manor Healthcare Ctr. Dmand AI also links Dr. Sheffy to 3 more hospitals, 5 medical groups, 2 group practices and clinics, 2 home health agencies, 2 hospices, 1 physician office and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheffy practices, 13 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Sheffy's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Sheffy's licenses on file in 6 states: Virginia, California, Iowa, New Jersey, New Mexico and Ohio.

CMS data shows 68 Medicare services from Dr. Sheffy across 3 procedure codes in 2024, for 47 Medicare patients. Medicare paid $6,939 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Sheffy in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheffy's median patient age at 79, with 60% women.

In 2024, Dr. Sheffy wrote 9,119 Medicare Part D claims for 834 patients. 86% of them were for generic drugs. CMS names the drug for 8,234 of them, across 147 drugs with 11 or more claims each, at $549,966 in total drug cost. In 2023, CMS named 6,713 claims across 113 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sheffy for performance year 2024, reported as part of a group. Dr. Sheffy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Sheffy from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $77.